Atlas Trials

Immune Checkpoint Inhibitors Rechallenge After Immune-related Adverse Events

Clinical trial NCT04169503 · UNKNOWN

Trial details

NCT number
NCT04169503
Sponsor
University Hospital, Caen
Status
UNKNOWN
Study type
OBSERVATIONAL
Cancer
Start date
2019-10-14
Primary completion
2020-01-01
Enrollment
17562

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.